Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1221-1230 of 1,291) with videos related to

Pageof 130
Sort By:
Blood|August 28, 2024
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analysesSikander Ailawadhi, Bertrand Arnulf, Krina Patel, et al.
Journal of Clinical Medicine|June 24, 2022
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM StudyAnna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Nature|June 25, 2016
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionJohannes F Scheid, Joshua A Horwitz, Yotam Bar-On, et al.
Parasites & Vectors|February 28, 2018
Spatial and temporal variation in the abundance of Culicoides biting midges (Diptera: Ceratopogonidae) in nine European countriesAna Carolina Cuéllar, Lene Jung Kjær, Carsten Kirkeby, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
Immunity|August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesTongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Parasites & Vectors|April 17, 2020
Modelling the monthly abundance of Culicoides biting midges in nine European countries using Random Forests machine learningAna Carolina Cuéllar, Lene Jung Kjær, Andreas Baum, et al.
Pageof 130

Showing results (1221-1230 of 1,291) with videos related to

Sort By:
Pageof 130
Blood|August 28, 2024
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analysesSikander Ailawadhi, Bertrand Arnulf, Krina Patel, et al.
Journal of Clinical Medicine|June 24, 2022
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM StudyAnna Waszczuk-Gajda, Olaf Penack, Giulia Sbianchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 TrialElias K Mai, Uta Bertsch, Ema Pozek, et al.
Nature|June 25, 2016
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionJohannes F Scheid, Joshua A Horwitz, Yotam Bar-On, et al.
Parasites & Vectors|February 28, 2018
Spatial and temporal variation in the abundance of Culicoides biting midges (Diptera: Ceratopogonidae) in nine European countriesAna Carolina Cuéllar, Lene Jung Kjær, Carsten Kirkeby, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
Immunity|August 6, 2013
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodiesTongqing Zhou, Jiang Zhu, Xueling Wu, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
The Journal of Experimental Medicine|November 1, 2024
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus diseaseAdrian Gervais, Paul Bastard, Lucy Bizien, et al.
Parasites & Vectors|April 17, 2020
Modelling the monthly abundance of Culicoides biting midges in nine European countries using Random Forests machine learningAna Carolina Cuéllar, Lene Jung Kjær, Andreas Baum, et al.
Pageof 130